MARKET

CHRN

CHRN

ChronoScale Holdings Corp
NASDAQ
20.42
+0.29
+1.44%
After Hours: 20.42 0 0.00% 16:10 09/18 EDT
OPEN
20.17
PREV CLOSE
20.13
HIGH
20.69
LOW
19.50
VOLUME
118.11K
TURNOVER
--
52 WEEK HIGH
30.00
52 WEEK LOW
3.500
MARKET CAP
2.97B
P/E (TTM)
-3.8662
1D
5D
1M
3M
1Y
5Y
1D
Why Wall Street is Bullish On The AI Service Market
Barron‘s · 2h ago
ChronoScale Holdings Price Target Announced at $32.00/Share by Northland Capital Markets
Dow Jones · 3h ago
ChronoScale Holdings Initiated at Outperform by Northland Capital Markets
Dow Jones · 3h ago
Northland Capital Markets Initiates Coverage On ChronoScale Holdings with Outperform Rating, Announces Price Target of $32
Benzinga · 3h ago
IREN Stock Pops as Northland Says Buy; 5-Star Analyst Sees Key AI Market Reaching $4 Trillion
TipRanks · 5h ago
Netflix downgraded, Etsy upgraded: Wall Street’s top analyst calls
TipRanks · 7h ago
Northland starts four new neocloud names at Outperform
TipRanks · 8h ago
ChronoScale amends term loan, extends debt maturity
TipRanks · 1d ago
More
About CHRN
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.

Webull offers Chronoscale Corp stock information, including NASDAQ: CHRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHRN stock methods without spending real money on the virtual paper trading platform.